Powering a New Generation of Physiologically-Relevant CRISPR Screens
CRISPR-Cas9 gene editing is an essential functional genomics tool, facilitating the cataloging of genomic variations linked to human diseases for the discovery and validation of novel drug targets. Despite its importance, many genes and regulatory elements remain poorly understood and many CRISPR-based screens lack translatability due to inadequate access to “CRISPR-ready” human cell models.
This webinar features Professor Luke Gilbert and Sejla Salic-Hainzl, who will discuss tools underpinning the next generation of genomic screens. Luke will explore scalable tools for characterizing genes, while Sejla will present advancements in iPSC-derived cell technologies for routine CRISPR-based knockouts.
In this webinar, you will:
- Learn about cutting-edge research and recently published data on advanced CRISPR screening technologies, including CRISPRi and CRISPRa
- Explore new data from functional genomic screens utilizing “CRISPR-ready” iPSC-derived neuronal and microglial models
- Gain insights into how CRISPR can be used to advance our understanding of human disease genetics towards the discovery of new therapeutics
Speakers
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
